Gloved analyst handling a volumetric flask of clear solution in a pharmaceutical QC laboratory — the setting where endotoxin testing and carbon depyrogenation screening are performed
Pharmaceutical · Depyrogenation

Activated Carbon for Pharmaceutical Purification

How activated carbon is used as a decolorization and endotoxin-reduction step in pharmaceutical processing: mechanism, where the technique is applied, and how to screen it against your own solution. Grade selection and documentation are confirmed per project. Contact us to discuss activated carbon options for your pharmaceutical purification process.

Wood PAC
Mesoporous grade used for this step
Batch
Contact in a stirred batch, then filtered
USP <85>
Bacterial endotoxins test / EP 2.6.14
Screening
Dosage set by trials on your own solution

Quick Answer

A carbon depyrogenation step normally uses acid-washed, mesoporous wood-based PAC (see the grade-selection criteria below). In a typical step the carbon is slurried into the solution, held in a stirred-batch contact, then removed by plate-and-frame or lenticular filtration. Dosage, contact time, and the endotoxin reduction you can achieve are matrix-dependent and must be set in your own process trials. Two endotoxin numbers are involved — the carbon's own content versus the reduction in your solution — and they are not the same thing (see below).

The Problem

Why Pharmaceutical Streams Need Depyrogenation

Bacterial endotoxins (lipopolysaccharides, LPS) are released by Gram-negative bacteria and survive heat sterilization. Even at trace levels, they trigger fever, septic shock, and organ failure in patients receiving injectables. Endotoxin limits are product-specific and set by the relevant pharmacopoeia monograph — the bacterial endotoxins test method itself is USP <85> / EP 2.6.14, and the compendial Water for Injection limit is commonly cited at ≤0.25 EU/mL. Confirm the exact limit for your product against the current monograph; any solution destined for parenteral use must pass a validated depyrogenation step.

Activated carbon is one option for reducing endotoxin load in aqueous API solutions, fermentation-derived streams, and water polishing. Whether it fits a given step — and whether product recovery stays acceptable — depends on the matrix and must be confirmed by bench-scale screening with your actual solution.

Fine-powder pharmaceutical-grade PAC for depyrogenation and endotoxin removal
Acid-washed wood-based PAC (200 mesh) of the type used for pharmaceutical decolorization and endotoxin-reduction evaluation.

How It Works

Endotoxin Removal and Process Evaluation

1 · Adsorption Mechanism

LPS endotoxins are large amphiphilic molecules (1–1,000 MDa aggregates) with a hydrophobic lipid-A tail and a hydrophilic polysaccharide chain. Activated carbon adsorbs them through combined hydrophobic and electrostatic interactions onto its high-surface-area structure. Mesopore-rich wood-based PAC provides the pore access these large molecules require.

2 · Batch Contact Step

Carbon is slurried into the solution at a dosage determined by bench-scale screening. Contact time, temperature, pH, and dosage vary by matrix — results from one API or solvent system cannot be transferred directly to another, so bench-scale trials with your actual solution are the starting point.

3 · Filtration

Carbon is removed by plate-and-frame filtration, lenticular (depth filter) cartridges, or pressure leaf filters. The filter system must be validated for bioburden, and the filtrate tested by LAL (Limulus Amoebocyte Lysate) assay to confirm it meets your process endotoxin limit — not the carbon's own specification.

Two Different Endotoxin Numbers — Read Carefully

You will see two distinct types of endotoxin data in this application. They measure different things and must not be conflated:

① Carbon endotoxin content

How much endotoxin the carbon itself carries, measured by LAL on a water extract of a specified lot. When this test is requested, the reported value is the endotoxin content of that batch of carbon — it describes the carbon as received, not how much endotoxin it will remove from your solution. Ask for the COA of the specific lot.

② Solution endotoxin reduction

The change in EU/mL (or EU/g) in your process solution before and after the carbon treatment step. This depends on your matrix, dosage, contact time, and initial load — it must be determined in your own process trials. We cannot and do not publish guaranteed removal percentages.

Container loading of bagged activated carbon alongside fine-powder PAC for pharmaceutical depyrogenation
Bagged activated carbon prepared for container shipment (left) and fine-powder PAC (right) of the type evaluated for pharmaceutical decolorization and endotoxin reduction.

Applicable Processes

Where Activated Carbon Depyrogenation Is Used

The table below lists pharmaceutical and biotech contexts where activated carbon is reported in the industry as an endotoxin-reduction or decolorization step. It is a map of where the technique is used generally — not a claim that any grade we supply has been validated in each stream. Suitability for any specific step depends on API chemistry, solvent, pH, and downstream processing, and must be confirmed by bench-scale screening with your own solution.

Process StreamTypical UseCarbon TypeNotes
Water for Injection (WFI) pre-treatmentEndotoxin polishing before distillation / UFAcid-washed wood PAC or GACSupplementary step — primary WFI production relies on distillation
Parenteral API solutionEndotoxin reduction + decolorizationAcid-washed wood PAC 200 meshBatch contact; LAL test on filtrate required
Biological API / fermentation brothEndotoxin and color removal from cell-culture mediaAcid-washed wood PACpH and ionic strength affect adsorption; screening required
Blood plasma / plasma derivativesPyrogen removal from fractionation streamsAcid-washed wood PACMust verify protein recovery; strict lot control
Small-volume parenterals (SVP)Endotoxin reduction in production solventAcid-washed wood PAC 200 meshProduct-specific endotoxin limit per applicable monograph

Carbon Selection

What to Specify When Selecting a Carbon

The parameters below are the ones that matter for a pharmaceutical decolorization or depyrogenation step, with the test method you should see on the certificate. Ask any supplier — including us — to state the actual value for the specific grade and lot they are offering, rather than a brochure range. Contact us to discuss activated carbon options for your pharmaceutical purification process and we will confirm the grade and the documentation available for it.

ParameterSpecificationTest Method
Base materialMesoporous wood-based PAC—
Particle size200 mesh (90% pass 75 μm)GB/T 7702.2
Methylene blue adsorption≥ 180 mg/gGB/T 7702.6
Iodine number≥ 900 mg/gGB/T 7702.7
Ash content≤ 3% (acid-washed)GB/T 7702.17
Moisture≤ 10%GB/T 7702.18
pH (water extract)3–5 (acid-washed)GB/T 7702.16
Heavy metals (as Pb)Confirm per grade/lot on COAUSP <232>/<233> / EP 2.4.8
Iron content≤ 500 ppmGB/T 7702.13
Soluble in HCl≤ 1%GB/T 7702.14
Endotoxin (LAL)Tested per lot on request — see COAUSP <85> / EP 2.6.14
About the LAL endotoxin number. When LAL testing is requested, the value reported on the COA is measured on a water extract of that specific production lot of carbon (USP <85> / EP 2.6.14 method). It tells you the endotoxin content of the carbon as received. It is nota measure of how much endotoxin the carbon will remove from your solution — that depends on your matrix, dosage, contact time, and initial load, and must be established through your own bench-scale LAL testing.

Documentation confirmed per project: TDS · COA (per batch) · SDS. Talk to our technical team about the grade and the documents available for it.

→ Related product: wood-based PAC for decolorization

Sample Evaluation

How to Screen Carbon for Your Depyrogenation Process

Carbon performance in depyrogenation is matrix-dependent. What works in one API solvent system may not be optimal in another. The evaluation sequence below is consistent with standard pharmaceutical development practice:

1 · Bench-scale screening

Test 2–4 dosages (e.g. 0.1%, 0.5%, 1%, 2% w/w) with your actual matrix. Stir 30 min at process temperature, filter, run LAL on the filtrate. Measure API recovery to confirm acceptable yield. We provide samples with COA and SDS for this step.

2 · Contact time optimization

Once a dosage range is shortlisted, vary contact time (15, 30, 60 min) to find the minimum time for consistent endotoxin reduction. Shorter contact is better for thermolabile APIs.

3 · Lot-to-lot reproducibility

Request 2–3 consecutive production lots for consistency testing. Each lot ships with a batch COA covering all parameters including endotoxin (for injectable-grade requests). This is the data set for validation dossiers and regulatory submissions.

4 · Scale-up and documentation

We supply consistent carbon with documentation confirmed per project: TDS, batch COA, and SDS. Scale-up quantities from 1 kg (sample) to FCL (25-kg bags or 500-kg super-sacks).

Ready to start screening?

Tell us your solution type, target endotoxin limit, and volume. We will send a sample with batch COA and suggest a starting dosage range.

Activated Carbon for Depyrogenation — Frequently Asked Questions

What activated carbon is used for depyrogenation?

Acid-washed wood-based powdered activated carbon (PAC) at 200 mesh (90% <75 μm) is the standard grade. Its predominantly mesoporous structure gives it access to the large LPS aggregates (1–1,000 MDa) that make up most bacterial endotoxins. Very low ash and controlled heavy metals prevent contaminating the product.

How does activated carbon remove endotoxins?

LPS molecules adsorb onto carbon through combined hydrophobic and electrostatic interactions. The lipid-A tail anchors to hydrophobic carbon surfaces; the polysaccharide chain interacts electrostatically with surface functional groups. Carbon is dosed into solution, stirred for 15–60 minutes, then filtered off — removing both the carbon and adsorbed endotoxins from the stream.

What is the difference between depyrogenation and endotoxin removal?

Pyrogens are any fever-inducing substance; bacterial endotoxins (LPS) are the most clinically relevant. Depyrogenation means removing pyrogens. In pharmaceutical manufacturing the terms are used almost interchangeably for the carbon treatment step, and endotoxin load is measured by the LAL assay (USP <85> / EP 2.6.14).

What is ≤5 EU/g on the carbon — does that mean the solution will meet 0.25 EU/mL?

No. ≤5 EU/g is the endotoxin content of the carbon itself, measured on a water extract. It describes the endotoxin content of that batch of carbon as received. The 0.25 EU/mL (or other) limit applies to your finished solution. Whether and to what extent your process solution meets that limit after carbon treatment depends on your initial load, dosage, contact time, and matrix — only your own bench-scale LAL tests can establish that.

Does activated carbon remove endotoxins from WFI?

Carbon can reduce endotoxin load in water streams and is sometimes used as a polishing step prior to WFI distillation or ultrafiltration. However, it is not validated as the primary WFI depyrogenation method — distillation, ultrafiltration, or validated reverse osmosis systems are the established primary methods. Carbon is used as a supplementary reduction step when endotoxin load upstream is high.

Can activated carbon remove endotoxins from biologic APIs?

Carbon can reduce endotoxin in cell-culture media, clarified fermentation broths, and some protein solutions. However, the same carbon that adsorbs endotoxins may also adsorb your protein or biological product. Recovery yield must be evaluated during screening before committing to this approach.

What documentation comes with the carbon?

Each lot ships with a batch Certificate of Analysis (COA), Technical Data Sheet (TDS), and Safety Data Sheet (SDS). LAL endotoxin testing is available on request and will be reported on the COA for that specific lot. For regulatory submissions, contact our technical team to confirm which supporting documentation can be provided for your required grade.

What is the minimum order quantity?

Minimum is 1 kg for sample evaluation. Commercial supply starts at 1 ton (25-kg bags or 500-kg super-sacks), with full FCL pricing for bulk orders. Lead time for pharmaceutical-grade with LAL testing is typically 15–25 days.

Need Pharmaceutical-Grade Carbon for Depyrogenation?

Tell us your solution type, target endotoxin limit (if known), and estimated volume. We respond within 24 hours with a sample, COA, and dosage starting point.

Response within 24 hours · Batch COA available · LAL endotoxin testing on request
Get Free Quote